Avid Bioservices Competitors and Similar CompaniesClear all
Avid Bioservices's competitors and similar companies include Just-Evotec Biologics, Durect, Sucampo Pharmaceuticals and BTG.
 Avid Bioservices Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company. |  Just-Evotec Biologics Just-Evotec Biologics is an integrated design company focused on the technology of biotherapeutics. |  Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. |  Sucampo Pharmaceuticals Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis. | ||
Founding Date | Founding Date 1981 | Founding Date 2014 | Founding Date N/A | Founding Date 1996 | Founding Date 1948 |
Type | Type Public | Type Private | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations Tustin, US HQ | Locations Seattle, US HQ | Locations Cupertino, US HQ | Locations Rockville, US HQ Chiyoda, JP Chuo Ward, JP Kita Ward, JP Sanda Shi, JP Zug, CH Milton, GB | |
Employees | Employees 21114% increase | Employees 6402% increase | Employees 902% increase | Employees 37 | Employees 650 |
Valuation ($) | Valuation ($) 649.4 m | Valuation ($) N/A | Valuation ($) 45.3 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $139.9m (FY, 2024) | Revenue (est.) $20m (Y, 2018) | Revenue (est.) $2m (FY, 2024) | Revenue (est.) $230.1m (FY, 2016) | Revenue (est.) £731.3m (FY, 2019) |
Cost of goods | Cost of goods $132.6m (FY, 2024) | Cost of goods N/A | Cost of goods $78k (FY, 2024) | Cost of goods $76m (FY, 2016) | Cost of goods £221m (FY, 2019) |
Gross profit | Gross profit $7.3m (FY, 2024) | Gross profit N/A | Gross profit $2m (FY, 2024) | Gross profit $154.1m (FY, 2016) | Gross profit £510.3m (FY, 2019) |
Net income | Net income ($140.8m) (FY, 2024) | Net income N/A | Net income ($8.3m) (FY, 2024) | Net income $18.5m (FY, 2016) | Net income £88.3m (FY, 2019) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 29m | Total funding raised $ 20m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Just-Evotec Biologics
HQ
Seattle, US
Employees
640↑ 2% increase
Just-Evotec Biologics is an integrated design company focused on the technology of biotherapeutics.
View companyDurect
HQ
Cupertino, US
Employees
90↑ 2% increase
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
View companySucampo Pharmaceuticals
HQ
Rockville, US
Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.
View company